| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 244.44 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 244.44. The average price that RMD shares were previous bought at was USD 251.553. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in RMD has fallen by USD 11,949 compared to the previous valuation of ResMed Inc |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 226.02 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 226.02. The average price that IQV shares were previous bought at was USD 197.449. The current market price is 14.5% higher than average price they were purchased at. The value of the holding in IQV has increased by USD 76,092 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 577.15 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 577.15. The average price that ISRG shares were previous bought at was USD 521.922. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in ISRG has fallen by USD 34,443 compared to the previous valuation of Intuitive Surgical Inc |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 207.78 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 207.78. The average price that JNJ shares were previous bought at was USD 176.182. The current market price is 17.9% higher than average price they were purchased at. The value of the holding in JNJ has increased by USD 2,464,036 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 254.46 | USD 0 | The current share valuation price of LH based on adjusted close was USD 254.46. The average price that LH shares were previous bought at was USD 257.319. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in LH has increased by USD 55,530 compared to the previous valuation of Laboratory Corporation of America Holdings however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1076.98 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1076.98. The average price that LLY shares were previous bought at was USD 855.47. The current market price is 25.9% higher than average price they were purchased at. The value of the holding in LLY has increased by USD 2,168,494 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| MCK - McKesson Corporation | HOLD | 0 @ USD 826.43 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 826.43. The average price that MCK shares were previous bought at was USD 713.456. The current market price is 15.8% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 44,270 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 97.27 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 97.27. The average price that MDT shares were previous bought at was USD 92.4182. The current market price is 5.2% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 131,175 compared to the previous valuation of Medtronic PLC |
| MOH - MOH | HOLD | 0 @ USD 163.47 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 163.47. The average price that MOH shares were previous bought at was USD 230.188. The current market price is -29.0% lower than average price they were purchased at. The value of the holding in MOH has fallen by USD 14,455 compared to the previous valuation of MOH |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 163.47 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 163.47. The average price that MOH shares were previous bought at was USD 230.188. The current market price is -29.0% lower than average price they were purchased at. The value of the holding in MOH has fallen by USD 14,455 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 106.45 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 106.45. The average price that MRK shares were previous bought at was USD 90.3852. The current market price is 17.8% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 1,791,442 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 106.45 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 106.45. The average price that MRK shares were previous bought at was USD 90.3852. The current market price is 17.8% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 1,791,442 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 32.75 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 32.75. The average price that MRNA shares were previous bought at was USD 30.2104. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in MRNA has increased by USD 80,578 compared to the previous valuation of Moderna Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1417.16 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1417.16. The average price that MTD shares were previous bought at was USD 1304.2. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 26,967 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1417.16 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1417.16. The average price that MTD shares were previous bought at was USD 1304.2. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 26,967 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.03 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.03. The average price that PFE shares were previous bought at was USD 25.38. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in PFE has increased by USD 436,116 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 288.82 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 288.82. The average price that PODD shares were previous bought at was USD 295.664. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in PODD has increased by USD 118,444 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 783.71 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 783.71. The average price that REGN shares were previous bought at was USD 663.29. The current market price is 18.2% higher than average price they were purchased at. The value of the holding in REGN has fallen by USD 75,212 compared to the previous valuation of Regeneron Pharmaceuticals Inc |
| INCY - Incyte Corporation | HOLD | 0 @ USD 100.44 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 100.44. The average price that INCY shares were previous bought at was USD 81.383. The current market price is 23.4% higher than average price they were purchased at. The value of the holding in INCY has fallen by USD 39,448 compared to the previous valuation of Incyte Corporation |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 96.78 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 96.78. The average price that RVTY shares were previous bought at was USD 102.657. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in RVTY has fallen by USD 45,909 compared to the previous valuation of Revvity Inc. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 80.18 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 80.18. The average price that SOLV shares were previous bought at was USD 74.2679. The current market price is 8.0% higher than average price they were purchased at. The value of the holding in SOLV has fallen by USD 27,603 compared to the previous valuation of Solventum Corp. |
| STE - STERIS plc | HOLD | 0 @ USD 255.68 | USD 0 | The current share valuation price of STE based on adjusted close was USD 255.68. The average price that STE shares were previous bought at was USD 238.397. The current market price is 7.2% higher than average price they were purchased at. The value of the holding in STE has increased by USD 14,664 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 354.74 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 354.74. The average price that SYK shares were previous bought at was USD 373.227. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 14,080 compared to the previous valuation of Stryker Corporation |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 59.19 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 59.19. The average price that TECH shares were previous bought at was USD 60.4872. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in TECH has fallen by USD 4,760 compared to the previous valuation of Bio-Techne Corp |
| TMO - Time Out Group plc | HOLD | 0 @ USD 579.12 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 579.12. The average price that TMO shares were previous bought at was USD 522.707. The current market price is 10.8% higher than average price they were purchased at. The value of the holding in TMO has fallen by USD 157,479 compared to the previous valuation of Time Out Group plc |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 227.08 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 227.08. The average price that UHS shares were previous bought at was USD 197.874. The current market price is 14.8% higher than average price they were purchased at. The value of the holding in UHS has fallen by USD 5,324 compared to the previous valuation of Universal Health Services Inc |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 327.58 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 327.58. The average price that UNH shares were previous bought at was USD 404.336. The current market price is -19.0% lower than average price they were purchased at. The value of the holding in UNH has increased by USD 1,287,724 compared to the previous valuation of UnitedHealth Group Incorporated however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 462.99 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 462.99. The average price that VRTX shares were previous bought at was USD 442.766. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in VRTX has increased by USD 490,425 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 12.24 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 12.24. The average price that VTRS shares were previous bought at was USD 10.4415. The current market price is 17.2% higher than average price they were purchased at. The value of the holding in VTRS has increased by USD 129,017 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 384.83 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 384.83. The average price that WAT shares were previous bought at was USD 354.08. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in WAT has increased by USD 48,871 compared to the previous valuation of Waters Corporation however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 384.83 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 384.83. The average price that WAT shares were previous bought at was USD 354.08. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in WAT has increased by USD 48,871 compared to the previous valuation of MULETFWATIMETFP however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 276.66 | USD 0 | The current share valuation price of WST based on adjusted close was USD 276.66. The average price that WST shares were previous bought at was USD 259.621. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in WST has fallen by USD 30,836 compared to the previous valuation of West Pharmaceutical Services Inc |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 90.23 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 90.23. The average price that ZBH shares were previous bought at was USD 100.947. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 80,790 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 125.49 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 125.49. The average price that ZTS shares were previous bought at was USD 150.325. The current market price is -16.5% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 441,111 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| CRL - Creightons Plc | HOLD | 0 @ USD 203.16 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 203.16. The average price that CRL shares were previous bought at was USD 169.734. The current market price is 19.7% higher than average price they were purchased at. The value of the holding in CRL has increased by USD 7,219 compared to the previous valuation of Creightons Plc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 229.89 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 229.89. The average price that ABBV shares were previous bought at was USD 207.679. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in ABBV has increased by USD 994,149 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 124.81 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 124.81. The average price that ABT shares were previous bought at was USD 128.576. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in ABT has increased by USD 240,082 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 157.84 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 157.84. The average price that ALGN shares were previous bought at was USD 166.66. The current market price is -5.3% lower than average price they were purchased at. The value of the holding in ALGN has increased by USD 37,269 compared to the previous valuation of Align Technology Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 333.96 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 333.96. The average price that AMGN shares were previous bought at was USD 305.214. The current market price is 9.4% higher than average price they were purchased at. The value of the holding in AMGN has increased by USD 680,132 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 19.11 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 19.11. The average price that BAX shares were previous bought at was USD 26.8865. The current market price is -28.9% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 47,088 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 196.12 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 196.12. The average price that BDX shares were previous bought at was USD 204.437. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 66,044 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 176.33 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 176.33. The average price that BIIB shares were previous bought at was USD 148.541. The current market price is 18.7% higher than average price they were purchased at. The value of the holding in BIIB has increased by USD 112,549 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 54.71 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 54.71. The average price that BMY shares were previous bought at was USD 51.8801. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in BMY has increased by USD 447,630 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 96.13 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 96.13. The average price that BSX shares were previous bought at was USD 99.0766. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in BSX has increased by USD 30,322 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 96.13 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 96.13. The average price that BSX shares were previous bought at was USD 99.0766. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in BSX has increased by USD 30,322 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 207.54 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 207.54. The average price that CAH shares were previous bought at was USD 155.302. The current market price is 33.6% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 20,535 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 274.86 | USD 0 | The current share valuation price of CI based on adjusted close was USD 274.86. The average price that CI shares were previous bought at was USD 297.292. The current market price is -7.5% lower than average price they were purchased at. The value of the holding in CI has increased by USD 151,899 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 39.89 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 39.89. The average price that CNC shares were previous bought at was USD 46.2429. The current market price is -13.7% lower than average price they were purchased at. The value of the holding in CNC has increased by USD 68,859 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 82.57 | USD 0 | The current share valuation price of COO based on adjusted close was USD 82.57. The average price that COO shares were previous bought at was USD 80.7971. The current market price is 2.2% higher than average price they were purchased at. The value of the holding in COO has fallen by USD 31,468 compared to the previous valuation of The Cooper Companies, Inc. Common Stock |
| COR - Cencora Inc. | HOLD | 0 @ USD 339.98 | USD 0 | The current share valuation price of COR based on adjusted close was USD 339.98. The average price that COR shares were previous bought at was USD 303.399. The current market price is 12.1% higher than average price they were purchased at. The value of the holding in COR has fallen by USD 60,548 compared to the previous valuation of Cencora Inc. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 138.32 | USD 0 | The current share valuation price of A based on adjusted close was USD 138.32. The average price that A shares were previous bought at was USD 131.468. The current market price is 5.2% higher than average price they were purchased at. The value of the holding in A has fallen by USD 5,785 compared to the previous valuation of Agilent Technologies Inc |
| CVS - CVS Health Corp | HOLD | 0 @ USD 79.12 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 79.12. The average price that CVS shares were previous bought at was USD 70.3565. The current market price is 12.5% higher than average price they were purchased at. The value of the holding in CVS has increased by USD 701,065 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 175.92 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 175.92. The average price that DGX shares were previous bought at was USD 175.667. The current market price is 0.1% higher than average price they were purchased at. The value of the holding in DGX has increased by USD 48,303 compared to the previous valuation of Quest Diagnostics Incorporated however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 231.47 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 231.47. The average price that DHR shares were previous bought at was USD 214.733. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 205,738 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 231.47 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 231.47. The average price that DHR shares were previous bought at was USD 214.733. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 205,738 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 114.41 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 114.41. The average price that DVA shares were previous bought at was USD 139.529. The current market price is -18.0% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 5,642 compared to the previous valuation of DaVita HealthCare Partners Inc |
| DXCM - DexCom Inc | HOLD | 0 @ USD 67.42 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 67.42. The average price that DXCM shares were previous bought at was USD 73.7855. The current market price is -8.6% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 111,848 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 343.3 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 343.3. The average price that ELV shares were previous bought at was USD 365.361. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 9,092 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 343.3 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 343.3. The average price that ELV shares were previous bought at was USD 365.361. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 9,092 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 86.29 | USD 0 | The current share valuation price of EW based on adjusted close was USD 86.29. The average price that EW shares were previous bought at was USD 76.0485. The current market price is 13.5% higher than average price they were purchased at. The value of the holding in EW has increased by USD 17,792 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 83.39 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 83.39. The average price that GEHC shares were previous bought at was USD 79.5018. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in GEHC has increased by USD 16,233 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 125.67 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 125.67. The average price that GILD shares were previous bought at was USD 112.195. The current market price is 12.0% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 304,528 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 474.06 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 474.06. The average price that HCA shares were previous bought at was USD 394.186. The current market price is 20.3% higher than average price they were purchased at. The value of the holding in HCA has increased by USD 1,634 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.5 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.5. The average price that HOLX shares were previous bought at was USD 68.9432. The current market price is 8.1% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 41,731 compared to the previous valuation of Hologic Inc |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 76.19 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 76.19. The average price that HSIC shares were previous bought at was USD 71.4262. The current market price is 6.7% higher than average price they were purchased at. The value of the holding in HSIC has fallen by USD 16,272 compared to the previous valuation of Henry Schein Inc |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 259.25 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 259.25. The average price that HUM shares were previous bought at was USD 265.449. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 130,153 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 259.25 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 259.25. The average price that HUM shares were previous bought at was USD 265.449. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 130,153 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 688.18 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 688.18. The average price that IDXX shares were previous bought at was USD 575.525. The current market price is 19.6% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 240,118 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-12-24 this would crystalise an overall loss. |